Please assess the completion status of the following clinical trial:

Trial Title: A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* healthy male volunteers~Exclusion Criteria:~* History of orthostatic hypotension~* History of prior radiation exposure for research purposes, or radiation therapy

- Gender: MALE
- Minimum Age: 21 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Cohort 1 - 20 mg (Type: EXPERIMENTAL): Cohort will include 4 HVs/completers who will receive a single 20 mg dose of PF-02545920.
- Cohort 2 ( adaptive dose, optional) (Type: EXPERIMENTAL): Cohort 2 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1.
- Cohort 3 ( adaptive dose, optional) (Type: EXPERIMENTAL): Cohort 3 will include 4 HVs/completers who will receive a single dose of PF-02545920. The dose will be selected based on the results obtained for Cohort 1.~Dose options range from 30 mg to 10 mg, 5 mg, 2mg, 1 mg. This cohort is optional

Based on this trial design, predict the completion outcome and termination type (if applicable).